The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance
暂无分享,去创建一个
A. Ruocco | M. Allegretti | M. Cesta | F. Rocchio | Rubina Novelli | P. G. Amendola | Mara Zippoli | Martina Sara Miscione
[1] Zhenyu Li,et al. Research progress of tumor‐derived extracellular vesicles in the treatment of malignant pleural effusion , 2022, Cancer medicine.
[2] C. Barja-Fidalgo,et al. Extracellular Vesicles Derived from MDA-MB-231 Cells Trigger Neutrophils to a Pro-Tumor Profile , 2022, Cells.
[3] Shiyu Zhang,et al. CXCL8 in Tumor Biology and Its Implications for Clinical Translation , 2022, Frontiers in Molecular Biosciences.
[4] R. Schicho,et al. Tumor-Mediated Neutrophil Polarization and Therapeutic Implications , 2022, International journal of molecular sciences.
[5] J. Spicer,et al. Neutrophil Extracellular Traps in Cancer Therapy Resistance , 2022, Cancers.
[6] Hongbo Zhang,et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy , 2022, Science advances.
[7] M. Baek,et al. Immune cell-derived small extracellular vesicles in cancer treatment. , 2021, BMB reports.
[8] C. Parent,et al. The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators , 2021, Frontiers in Immunology.
[9] T. Whiteside,et al. Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells. , 2021, Cytokine & growth factor reviews.
[10] P. Cui,et al. Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles , 2021, BMC cancer.
[11] R. Sumagin,et al. Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance , 2021, Expert opinion on therapeutic targets.
[12] Hang-zi Chen,et al. Extracellular vesicles in the tumor immune microenvironment. , 2021, Cancer letters.
[13] C. Barja-Fidalgo,et al. Melanoma‐derived extracellular vesicles skew neutrophils into a pro‐tumor phenotype , 2021, Journal of leukocyte biology.
[14] F. Brimo,et al. Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer , 2021, Nature Communications.
[15] M. Spitzer,et al. Systemic immunity in cancer , 2021, Nature Reviews Cancer.
[16] L. Wiesmüller,et al. Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer. , 2021, Gastroenterology.
[17] Guibo Sun,et al. Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke , 2021, Oxidative medicine and cellular longevity.
[18] G. Nie,et al. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin. , 2021, International immunopharmacology.
[19] E. Nice,et al. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment , 2021, Frontiers in Cell and Developmental Biology.
[20] Daniel Xin Zhang,et al. Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic resistance. , 2021, Seminars in cancer biology.
[21] L. Muinelo-Romay,et al. Circulating Free DNA and Its Emerging Role in Autoimmune Diseases , 2021, Journal of personalized medicine.
[22] M. Tarnopolsky,et al. Extracellular Vesicles and Exosomes: Insights From Exercise Science , 2021, Frontiers in Physiology.
[23] Q. Yang,et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. , 2020, Cancer cell.
[24] K. Schalper,et al. IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy , 2020, Clinical Cancer Research.
[25] E. Ligeti,et al. The Functional Heterogeneity of Neutrophil-Derived Extracellular Vesicles Reflects the Status of the Parent Cell , 2020, Cells.
[26] J. Quigley,et al. Neutrophil Elastase Facilitates Tumor Cell Intravasation and Early Metastatic Events , 2020, iScience.
[27] Kristen Fousek,et al. Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. , 2020, Pharmacology & therapeutics.
[28] M. Minopoli,et al. The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis , 2020, Frontiers in Immunology.
[29] A. Maitra,et al. Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer , 2020, The Journal of experimental medicine.
[30] C. Mermelstein,et al. Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial–Mesenchymal Transition , 2020, Cancers.
[31] Y. Assaraf,et al. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[32] Wei Liu,et al. Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity , 2020, Frontiers in Oncology.
[33] M. Carleton,et al. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity. , 2020, Immunity.
[34] Dong Li,et al. Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression , 2020, Cell Communication and Signaling.
[35] N. Beauchemin,et al. Neutrophil Extracellular Trap–Associated CEACAM1 as a Putative Therapeutic Target to Prevent Metastatic Progression of Colon Carcinoma , 2020, The Journal of Immunology.
[36] S. Camerini,et al. Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors , 2020, Frontiers in Immunology.
[37] Yihai Cao,et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation , 2020, Nature Communications.
[38] R. Dummer,et al. Targeting complex, adaptive responses in melanoma therapy. , 2020, Cancer treatment reviews.
[39] Hannah Stower. Understanding cancer genetics through a global collaboration , 2020, Nature Medicine.
[40] Y. Assaraf,et al. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[41] Pengfei Wu,et al. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis , 2020, Cancer biology & medicine.
[42] D. Yang,et al. Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance , 2019, Acta pharmaceutica Sinica. B.
[43] A. Tsung,et al. Neutrophil Elastase and Neutrophil Extracellular Traps in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.
[44] A. Vecchione,et al. Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer. , 2019, Cancer research.
[45] J. Schlom,et al. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models , 2019, Clinical Cancer Research.
[46] B. Boone,et al. Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment , 2019, Breast Cancer Research.
[47] Jiye Cai,et al. Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance , 2019, Molecular Cancer.
[48] M. Minopoli,et al. Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy , 2019, Front. Oncol..
[49] Neil Vasan,et al. A view on drug resistance in cancer , 2019, Nature.
[50] M. Shaul,et al. Tumour-associated neutrophils in patients with cancer , 2019, Nature Reviews Clinical Oncology.
[51] H. Naora,et al. Neutrophils fertilize the pre-metastatic niche , 2019, Aging.
[52] J. Schlom,et al. Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors , 2019, Journal of Immunotherapy for Cancer.
[53] Cierra S. Hong,et al. Neutrophils promote tumor resistance to radiation therapy , 2019, Proceedings of the National Academy of Sciences.
[54] Robert H. Jenkins,et al. Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis , 2019, Scientific Reports.
[55] T. Whiteside. Human regulatory T cells (Treg) and their response to cancer , 2019, Expert review of precision medicine and drug development.
[56] Michael Zhuo Wang,et al. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis , 2019, Cells.
[57] M. Gunzer,et al. Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions , 2019, Front. Immunol..
[58] H. Nishikawa,et al. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? , 2019, Cancer science.
[59] Huajun Zhao,et al. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape , 2019, Cells.
[60] Yan Li,et al. Extracellular RNAs from lung cancer cells activate epithelial cells and induce neutrophil extracellular traps , 2019, International journal of oncology.
[61] A. Hidalgo,et al. Neutrophils as regulators of the hematopoietic niche. , 2019, Blood.
[62] W. Lu,et al. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. , 2019, Developmental cell.
[63] C. Alfaro,et al. Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role? , 2019, Journal of immunology research.
[64] P. Ruffini. The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells , 2019, Front. Oncol..
[65] S. Hanauer,et al. Neutrophil‐induced genomic instability impedes resolution of inflammation and wound healing , 2019, The Journal of clinical investigation.
[66] Wei-Chung Cheng,et al. Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer , 2019, Journal of Hematology & Oncology.
[67] H. Rui,et al. An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles. , 2019, Cancer cell.
[68] D. Schadendorf,et al. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. , 2019, The New England journal of medicine.
[69] R. Alon,et al. Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis , 2018, Immunity.
[70] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[71] Jiayuh Lin,et al. Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells , 2018, AntiCancer Research.
[72] H. Qian,et al. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration , 2018, Molecular Cancer.
[73] Kentaro Inoue,et al. Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study , 2018, Oncotarget.
[74] J. Schlom,et al. Phase I trial of BMS-986253, an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. , 2018 .
[75] H. Watz,et al. Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils , 2018, European Respiratory Journal.
[76] J. Rhim,et al. Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells , 2018, Scientific Reports.
[77] C. Rosales. Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? , 2018, Front. Physiol..
[78] P. Pandolfi,et al. The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer , 2018, Molecular Cancer Research.
[79] R. Hutchins,et al. Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis , 2018, Journal of surgical oncology.
[80] C. Vetro,et al. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy , 2018, Annals of Hematology.
[81] S. Nomura,et al. Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab , 2018, International Journal of Clinical Oncology.
[82] Wenxin Qin,et al. Exosomes as a liquid biopsy for lung cancer. , 2018, Lung cancer.
[83] Graça Raposo,et al. Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.
[84] A. Mantovani,et al. Roles of neutrophils in cancer growth and progression , 2017, Journal of leukocyte biology.
[85] S. Hammes,et al. Neutrophil elastase in the tumor microenvironment , 2017, Steroids.
[86] P. Ascierto,et al. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[87] M. Fabbri,et al. Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.
[88] H. Albadawi,et al. Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis. , 2017, Cardiovascular diagnosis and therapy.
[89] H. Arkenau,et al. Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade , 2017, BioMed research international.
[90] Kristen K. McCampbell,et al. Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. , 2017, JCI insight.
[91] T. Standiford,et al. Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice , 2017, Science Translational Medicine.
[92] M. Wiese,et al. Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers , 2017, British Journal of Cancer.
[93] A. Alli,et al. Lipidomic and proteomic analysis of exosomes from mouse cortical collecting duct cells , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[94] Na Li,et al. Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer , 2017, Cell biochemistry and function.
[95] N. C. Rochael,et al. Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis , 2017, Scientific Reports.
[96] H. Saji,et al. Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells , 2017, Cancer science.
[97] G. Merlino,et al. Genetically engineered mouse models of melanoma , 2017, Cancer.
[98] X. Q. Wang,et al. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance , 2017, BMC Cancer.
[99] J. Spicer,et al. Neutrophil extracellular traps sequester circulating tumor cells via β1‐integrin mediated interactions , 2017, International journal of cancer.
[100] I. Bièche,et al. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know? , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[101] Yingwei Xue,et al. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[102] R. Melillo,et al. Multiple anti-tumor effects of Reparixin on thyroid cancer , 2017, Oncotarget.
[103] M. Rugge,et al. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis , 2017, American journal of clinical pathology.
[104] P. Metharom,et al. Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis , 2017, International journal of molecular sciences.
[105] Xiao-dong Guo,et al. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. , 2017, Biochemical and biophysical research communications.
[106] Joshua M. Weiss,et al. Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.
[107] B. Garcia,et al. Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2016, Nature Network Boston.
[108] Michael S. Goldberg,et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps , 2016, Science Translational Medicine.
[109] R. Mlak,et al. Metastatic potential of NET in neoplastic disease. , 2016, Postepy higieny i medycyny doswiadczalnej.
[110] A. Shapiro,et al. Reparixin, a CXCR1/2 inhibitor in islet allotransplantation , 2016, Islets.
[111] K. E. Visser,et al. Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.
[112] P. Ascierto,et al. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[113] I. Melero,et al. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs) , 2016, Clinical Cancer Research.
[114] I. Malanchi,et al. Neutrophils support lung colonization of metastasis-initiating breast cancer cells , 2015, Nature.
[115] S. Jurcevic,et al. The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions. , 2015, British journal of clinical pharmacology.
[116] Li-hua Shang,et al. Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer , 2015, Scientific Reports.
[117] A. Giraud,et al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. , 2015, Blood.
[118] R. Koch,et al. Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone , 2015, Clinical Cancer Research.
[119] Leonora Balaj,et al. Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study. , 2015, Bioscience.
[120] B. Miller,et al. The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects , 2015, BMC Pharmacology and Toxicology.
[121] Michael A. Hollingsworth,et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.
[122] Frances M. G. Pearl,et al. Therapeutic opportunities within the DNA damage response , 2015, Nature Reviews Cancer.
[123] J. Jonkers,et al. IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.
[124] E. Passegué,et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.
[125] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[126] T. Niki,et al. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells. , 2015, Journal of the National Cancer Institute.
[127] Yibin Kang,et al. Regulation of cancer metastasis by cell-free miRNAs. , 2015, Biochimica et biophysica acta.
[128] C. Théry,et al. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.
[129] Lianyu Chen,et al. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases , 2014, Scientific Reports.
[130] P. Altevogt,et al. Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation , 2014, Journal of Neuroimmunology.
[131] G. Blandino,et al. Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells , 2014, Oncogene.
[132] D. Wagner,et al. NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis , 2014, Seminars in Thrombosis & Hemostasis.
[133] D. Hanahan. Rethinking the war on cancer , 2014, The Lancet.
[134] E. Pinatel,et al. miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions , 2014, PloS one.
[135] R. Pink,et al. Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.
[136] F. Meric-Bernstam,et al. Targeting the PI3-kinase/Akt/mTOR signaling pathway. , 2013, Surgical oncology clinics of North America.
[137] Zhaoshi Jiang,et al. An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy , 2013, Nature Medicine.
[138] Paul Kubes,et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. , 2013, The Journal of clinical investigation.
[139] E. Montgomery,et al. microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1 , 2013, Clinical Cancer Research.
[140] K. Gravdal,et al. Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. , 2013, Cancer discovery.
[141] M. Ringnér,et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development , 2013, Proceedings of the National Academy of Sciences.
[142] Rakesh K. Singh,et al. Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis , 2013, Molecular Cancer Therapeutics.
[143] Graça Raposo,et al. Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.
[144] S. Fais. NK cell-released exosomes , 2013, Oncoimmunology.
[145] Wilfrid Boireau,et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth , 2012, Nature Medicine.
[146] D. Scadden,et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis , 2012, Proceedings of the National Academy of Sciences.
[147] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[148] S. Albelda,et al. Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.
[149] H. Lenz,et al. The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models , 2012, Molecular Cancer Therapeutics.
[150] Qiang Hu,et al. Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism , 2011, PloS one.
[151] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[152] Sophia Hsin-Jung Li,et al. Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.
[153] Aihua Li,et al. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. , 2011, Cancer letters.
[154] D. Birnbaum,et al. Targeting breast cancer stem cells: fishing season open! , 2010, Breast Cancer Research.
[155] Daniel G Tenen,et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. , 2010, Blood.
[156] D. Birnbaum,et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. , 2010, The Journal of clinical investigation.
[157] B. Chauffert,et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.
[158] B. Chauffert,et al. Membrane-associated Hsp 72 from tumor-derived exosomes mediates STAT 3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells , 2010 .
[159] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[160] K. Rajarathnam,et al. Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer1 , 2009, The Journal of Immunology.
[161] Benjamin Haibe-Kains,et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. , 2009, Blood.
[162] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[163] Valérie Ferreira,et al. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. , 2008, European journal of cancer.
[164] M. Fiorentino,et al. Quantification of Free Plasma DNA Before and After Chemotherapy in Patients With Advanced Epithelial Ovarian Cancer , 2008, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[165] Thomas Helleday,et al. DNA repair pathways as targets for cancer therapy , 2008, Nature Reviews Cancer.
[166] Jorge S. Reis-Filho,et al. Resistance to therapy caused by intragenic deletion in BRCA2 , 2008, Nature.
[167] M. Billah,et al. A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation , 2007, Journal of Pharmacology and Experimental Therapeutics.
[168] O. Rath,et al. MAP kinase signalling pathways in cancer , 2007, Oncogene.
[169] Christopher Chiu,et al. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.
[170] Alessandro Fatica,et al. A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.
[171] S. Chakrabarti,et al. Regulation of matrix metalloproteinase‐9 release from IL‐8‐stimulated human neutrophils , 2005, Journal of leukocyte biology.
[172] M. Luisa Iruela-Arispe,et al. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors , 2005, The Journal of cell biology.
[173] Erwin G. Van Meir,et al. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.
[174] M. Schuler,et al. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia , 1995, Annals of Hematology.
[175] Jeremy J. W. Chen,et al. The role of interleukin-8 in cancer cells and microenvironment interaction. , 2005, Frontiers in bioscience : a journal and virtual library.
[176] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[177] S. Rankin,et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.
[178] K. Xie,et al. Interleukin-8 and human cancer biology. , 2001, Cytokine & growth factor reviews.
[179] J. Abbruzzese,et al. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[180] J. Abbruzzese,et al. Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[181] K. Matsushima,et al. Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[182] D. Schadendorf,et al. Expression of interleukin‐8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma , 1999, The Journal of pathology.
[183] I. Fidler,et al. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice , 1999, British Journal of Cancer.
[184] T. Out,et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. , 1999, Gynecologic oncology.
[185] R. Vessella,et al. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. , 1999, Urology.
[186] A. Mantovani,et al. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours. , 1998, Molecular pathology : MP.
[187] V. Laudone,et al. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. , 1998, Urology.
[188] A. Green,et al. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin‐8 as a potential regulatory factor in breast tumours , 1997, International journal of cancer.
[189] R. Ramesh,et al. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. , 1996, Human pathology.
[190] C. Scheibenbogen,et al. Serum interleukin‐8 (IL‐8) is elevated in patients with metastatic melanoma and correlates with tumour load , 1995, Melanoma research.
[191] R. Foà,et al. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. , 1994, Blood.
[192] R. Whyte,et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.
[193] K. Matsushima,et al. Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues. , 1993, European cytokine network.
[194] F. Herrmann,et al. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. , 1992, Cancer research.
[195] K. Matsushima,et al. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. , 1992, Chemical immunology.
[196] M. Baggiolini,et al. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.